National Health Investors held its Second Quarter 2026 Earnings Webcast and Conference Call on Tuesday, August 11, 2026, reporting net income per share of $1.15, a 45.6% increase from the prior year's second quarter, driven largely by a $22 million gain on the sale of real estate. The company completed the sale of the NHC portfolio on July 1 for cash consideration of $560 million, expecting to recognize a gain of approximately $541.6 million in the third quarter, with about $221 million of proceeds used for replacement properties under reverse Section 1031 exchanges and the remaining $334 million held for future tax-deferred reinvestment. NHI's SHOP portfolio grew 137% over the past year to approximately $850 million, representing 24% of the company's total, and total SHOP net operating income increased 188.5% compared to the second quarter of 2025. The Board of Directors declared a $0.02 per share increase to the quarterly dividend, raising it to $0.94 per share for stockholders of record on September 30, 2026, payable November 6, 2026. Management also announced the appointment of Chris Maingot as Chief Operating Officer and Todd Siefert as Chief Financial Officer, effective July 1, 2026.
National Health Investors IncQ2 earnings beat with 45.6% EPS growth, $560M NHC portfolio sale gain, dividend increase, and new executives.
